CompletedPhase 2NCT03614533
Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso
Studying Typhoid
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Maryland, Baltimore
- Principal Investigator
- Laurens Matthew, MDUniversity of Maryland, Baltimore
- Intervention
- Vi-Typhoid Conjugate Vaccine (Vi-TCV)(biological)
- Enrollment
- 251 target
- Eligibility
- All sexes
- Timeline
- 2018 – 2024
Study locations (1)
- Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso
Collaborators
Bill and Melinda Gates Foundation · Groupe de Recherche Action en Sante
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03614533 on ClinicalTrials.govOther trials for Typhoid
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGEARLY PHASE1NCT04083950Induction of Gut Permeability by an Oral VaccineUSDA, Western Human Nutrition Research Center
- ACTIVE NOT RECRUITINGPHASE3NCT03299426Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, MalawiUniversity of Maryland, Baltimore
- ACTIVE NOT RECRUITINGPHASE4NCT03970304CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated AdultsUniversity of Maryland, Baltimore